What is Shift Labs?
Shift Labs is a medical technology company focused on enhancing patient safety and efficiency in infusion therapy. Its flagship product, the DripAssist Infusion Rate Monitoring Platform, is the first FDA-cleared device designed to monitor gravity IV infusions accurately. This technology is crucial for various healthcare settings, including home care, veterinary medicine, and public health initiatives, offering a more affordable and reliable alternative to traditional infusion pumps. The platform's ability to ensure precise medication delivery contributes to improved patient outcomes and reduced healthcare operational costs.
How much funding has Shift Labs raised?
Shift Labs has raised a total of $1.3M across 2 funding rounds:
Unspecified
$1.2M
Debt
$96K
Unspecified (2015): $1.2M, investors not publicly disclosed
Debt (2021): $96K led by PPP
What's next for Shift Labs?
With the recent influx of substantial expansion capital, Shift Labs is poised for significant growth and further market penetration. The company's focus on innovation in infusion therapy, particularly for gravity-based systems, positions it to address critical needs in home care and beyond. Future strategic initiatives will likely involve scaling production, expanding its sales and distribution networks, and potentially developing next-generation monitoring solutions to further solidify its market leadership in infusion accuracy and patient safety.
See full Shift Labs company page
